Be Familiar With New Meds for Myasthenia Gravis

There’s buzz about new injectable targeted therapies for myasthenia gravis.

This chronic, autoimmune disease can cause bouts of muscle weakness almost anywhere in the body...from drooping eyelids to difficulty swallowing, speaking, and moving.

These patients’ immune systems make antibodies...mostly to acetylcholine receptors...which attack proteins in the muscle neural pathways making it hard to contract muscles.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote